Russell Investments Group, Ltd. Halozyme Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 319,380 shares of HALO stock, worth $17.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

319,380

Previous 410,284 22.16%

Holding current value

$17.2 Million

Previous $21.5 Million 14.95%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.3 - $64.42 $4.66 Million - $5.86 Million	-90,904 Reduced 22.16%	319,380 $18.3 Million
Q2 2024 Aug 08, 2024	BUY	$37.81 - $52.4 $4.22 Million - $5.85 Million	111,734 Added 37.43%	410,284 $21.5 Million
Q1 2024 May 08, 2024	SELL	$33.68 - $41.95 $2.06 Million - $2.57 Million	-61,156 Reduced 17.0%	298,550 $12.1 Million
Q4 2023 Feb 05, 2024	SELL	$33.32 - $42.1 $2.1 Million - $2.65 Million	-62,986 Reduced 14.9%	359,706 $13.3 Million
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $9.07 Million - $10.9 Million	248,693 Added 142.93%	422,692 $16.1 Million
Q2 2023 Aug 10, 2023	SELL	$30.28 - $38.74 $996,969 - $1.28 Million	-32,925 Reduced 15.91%	173,999 $6.28 Million
Q1 2023 May 09, 2023	SELL	$32.86 - $55.7 $1.16 Million - $1.96 Million	-35,235 Reduced 14.55%	206,924 $7.9 Million
Q4 2022 Feb 08, 2023	SELL	$40.06 - $59.44 $1.15 Million - $1.71 Million	-28,762 Reduced 10.62%	242,159 $13.8 Million
Q3 2022 Nov 04, 2022	SELL	$38.53 - $51.78 $81,182 - $109,100	-2,107 Reduced 0.77%	270,921 $10.7 Million
Q2 2022 Jul 29, 2022	BUY	$37.35 - $48.3 $4.17 Million - $5.39 Million	111,597 Added 69.13%	273,028 $12 Million
Q1 2022 May 05, 2022	BUY	$31.97 - $41.06 $2.99 Million - $3.84 Million	93,439 Added 137.43%	161,431 $6.44 Million
Q4 2021 Jan 21, 2022	SELL	$31.82 - $40.75 $260,096 - $333,090	-8,174 Reduced 10.73%	67,992 $2.73 Million
Q3 2021 Nov 08, 2021	SELL	$38.47 - $46.42 $538,926 - $650,297	-14,009 Reduced 15.54%	76,166 $3.1 Million
Q2 2021 Aug 04, 2021	SELL	$38.84 - $51.31 $4.84 Million - $6.39 Million	-124,492 Reduced 57.99%	90,175 $4.09 Million
Q1 2021 May 10, 2021	BUY	$39.51 - $51.45 $784,036 - $1.02 Million	19,844 Added 10.19%	214,667 $8.95 Million
Q4 2020 Feb 08, 2021	SELL	$25.81 - $43.62 $147,271 - $248,895	-5,706 Reduced 2.85%	194,823 $8.32 Million
Q3 2020 Nov 09, 2020	BUY	$25.74 - $29.63 $857,425 - $987,004	33,311 Added 19.92%	200,529 $5.27 Million
Q2 2020 Aug 05, 2020	BUY	$16.25 - $26.81 $560,153 - $924,167	34,471 Added 25.97%	167,218 $4.48 Million
Q1 2020 May 06, 2020	BUY	$13.9 - $21.83 $371,505 - $583,450	26,727 Added 25.21%	132,747 $2.39 Million
Q4 2019 Jan 29, 2020	BUY	$14.93 - $19.53 $119,693 - $156,572	8,017 Added 8.18%	106,020 $1.88 Million
Q3 2019 Nov 01, 2019	SELL	$15.2 - $17.69 $678,330 - $789,451	-44,627 Reduced 31.29%	98,003 $1.52 Million
Q2 2019 Aug 09, 2019	SELL	$14.75 - $17.26 $1.14 Million - $1.33 Million	-77,063 Reduced 35.08%	142,630 $2.45 Million
Q1 2019 May 13, 2019	SELL	$13.94 - $17.58 $228,462 - $288,118	-16,389 Reduced 6.94%	219,693 $3.54 Million
Q4 2018 Feb 11, 2019	BUY	$13.33 - $18.66 $606,741 - $849,347	45,517 Added 23.89%	236,082 $3.45 Million
Q3 2018 Oct 26, 2018	BUY	$16.68 - $18.41 $199,509 - $220,202	11,961 Added 6.7%	190,565 $3.46 Million
Q2 2018 Aug 08, 2018	SELL	$16.87 - $20.3 $2.66 Million - $3.2 Million	-157,419 Reduced 46.85%	178,604 $3.01 Million
Q1 2018 May 11, 2018	SELL	$17.06 - $21.2 $3.87 Million - $4.81 Million	-226,938 Reduced 40.31%	336,023 $6.58 Million
Q4 2017 Feb 06, 2018	BUY	$16.75 - $20.8 $7.21 Million - $8.96 Million	430,668 Added 325.54%	562,961 $11.7 Million
Q3 2017 Nov 07, 2017	BUY	$11.76 - $17.4 $1.56 Million - $2.3 Million	132,293	132,293 $2.3 Million

Others Institutions Holding HALO

# of Institutions

536

Shares Held

124M

Call Options Held

177K

Put Options Held

167K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.52B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Halozyme Therapeutics, Inc. Transaction History